980-nm Diode Laser: A Novel Laser Technology for Vaporization of the Prostate
|
|
- Imogene Nelson
- 6 years ago
- Views:
Transcription
1 european urology 52 (2007) available at journal homepage: Benign Prostatic Obstruction 980-nm Diode Laser: A Novel Laser Technology for Vaporization of the Prostate Gunnar Wendt-Nordahl *, Stephanie Huckele, Patrick Honeck, Peter Alken, Thomas Knoll, Maurice Stephan Michel, Axel Häcker Department of Urology, University Hospital Mannheim, Mannheim, Germany Article info Article history: Accepted June 18, 2007 Published online ahead of print on June 26, 2007 Keywords: Benign prostatic enlargement Bleeding KTP laser Tissue ablation Transurethral resection of the prostate Abstract Objective: The wavelength 980 nm of a recently introduced diode laser system for treatment of benign prostatic enlargement offers a high simultaneous absorption in water and haemoglobin, and is postulated to combine high tissue ablative properties with a good haemostasis. Methods: The Ceralas HPD150 diode laser system was evaluated in the well-established ex vivo model of the isolated blood-perfused porcine kidney to evaluate tissue ablation capacity and haemostatic properties at different generator settings. A histological examination of the ablated renal tissue followed. The results were compared with the reference standards transurethral resection of the prostate (TURP) and potassiumtitanyl-phosphate (KTP) laser. Results: The diode laser displays a higher tissue ablation capacity, reaching g after 10 min, compared with the KTP laser ( g; p < 0.05), whereas only 30 s are needed to resect the tissue in the same surface area using TURP, resulting in g of tissue removal. With a bleeding rate of g/min, the diode laser offers haemostatic properties equivalent to the KTP laser ( g/min) and a significantly reduced bleeding compared with TURP ( g/min; p < 0.05). The corresponding depths of the coagulation zones are mm for the diode laser, mm for the KTP laser ( p < 0.05), and mm for TURP. Conclusions: In the standardised ex vivo investigation, the 980-nm diode laser offers a higher tissue ablation capacity and similar haemostasis compared with the KTP laser. In comparison with TURP, both tissue ablation and bleeding are significantly reduced. The promising ex vivo results warrant further clinical investigation. # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. * Corresponding author. Department of Urology, University Hospital Mannheim, Theodor-Kutzer-Ufer 1 3, Mannheim, Germany. Tel ; Fax: address: gunnar.wendt-nordahl@uro.ma.uni-heidelberg.de (G. Wendt-Nordahl) /$ see back matter # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eururo
2 1724 european urology 52 (2007) Introduction Although transurethral resection of the prostate (TURP) is still considered the reference standard in surgical therapy of benign prostatic enlargement (BPE), it has been challenged by several alternative treatment modalities that try to match the efficacy of TURP but do reduce perioperative morbidity [1].In this context, several laser devices working on various wavelengths have been introduced in the last few decades [2,3]. The neodymium:yttrium-aluminum-garnet (Nd: YAG) laser (wavelength, 1064 nm) has a low absorption coefficient in tissue, and displays a deep penetration and a low energy density, resulting in coagulation necrosis without immediate ablative effects. In contrast, the holmium:yag (Ho:YAG) laser (wavelength, 2140 nm) is highly absorbed in prostatic tissue, and has a short penetration depth and a highenergy density. It heats the tissue above the boiling point and produces instant removal by vaporization. The physical properties of the lately introduced potassium-titanyl-phosphate laser (KTP laser), operating on a wavelength of 532 nm, offer an excellent haemostasis because the laser is highly absorbed by haemoglobin [4]. Its ablative properties are rather slow because the absorption in water is minimal, resulting in prolonged operation times [5,6]. A recently introduced diode laser system operates on a wavelength of 980 nm. Because this wavelength offers a high simultaneous absorption in water and haemoglobin, it is postulated to combine high tissue ablative properties with good haemostasis. In this study the diode laser was evaluated in an ex vivo model to determine its ablative and haemostatic properties systematically and to compare the results against TURP and KTP lasers as reference standard methods. 2. Methods 2.1. Equipment The Ceralas HPD150 (Biolitec-AG, Jena, Germany) is a diode laser system emitting a wavelength of 980 nm. The light is transmitted via a flexible 600-mm side-fire fibre to vaporize the tissue in a noncontact mode. The laser was evaluated at output power levels of 30, 50, 60, 80, 100, and 120 W in the continuous wave (cw) mode. Furthermore, the pulsed mode was tested with a fixed pulse length of 0.1 s and pause lengths of 0.01, 0.05, and 0.1 s at an output power of 100 W. TURP was performed with the use of a standard monopolar resectoscope (Karl Storz, Tuttlingen, Germany) activated by a high-frequency generator (Autocon II, Karl Storz) and set to an output power of 160 W, coagulation degree 2. Mannitol/sorbitol solution (Purisole SM, Fresenius, Bad Homburg, Germany) was used for irrigation. KTP laser ablation was performed with the use of the GreenLight PV laser generator (Laserscope, USA) and 600-mm side-fire fibres. An output power of 80 W was used in all experiments Ex vivo experiments The well-established model of the isolated blood-perfused porcine kidney was used to determine tissue ablation and haemostatic properties of the diode laser, the KTP laser, and TURP as previously described [7,8]. Porcine kidneys were removed immediately after slaughtering (Mannheim city slaughterhouse). After catheterisation of the renal artery and vein with a 10F catheter, the kidneys were perfused with 0.9% sodium chloride solution until the effluent was clear. Autologous blood was harvested and anticoagulized with sodium citrate. The kidneys and the blood were stored at 4 8C until the experiments started. The trials were performed in an acryl basin containing 0.9% sodium chloride solution at a temperature of 37 8C. All experiments were done by the same surgeon. Five experiments were performed per output power level and device; one kidney was used per experiment. Before commencing the experiments, each kidney was put in the basin for 30 min to adapt to the temperature. For the evaluation of tissue ablation, the catheters in the renal artery and vein were removed and the vessels were ligated. After removal of the capsule, the kidneys were weighed. Different output power levels were used to ablate the renal tissue in an area of 3 3 cm. The kidneys were weighed after 5, 10, and 15 min to determine the time-dependent amount of tissue ablation. Similarly, an area of 3 3 cm was resected with a drag speed of 1 cm/s to determine the amount of tissue removal by TURP. To evaluate the haemostatic properties of the devices, we perfused the kidneys with autologous blood by a roller pump via the catheter in the renal artery. The blood was drained from the kidney through the catheter in the renal vein to ensure a clear vision in the basin. The perfusion rate was set to 80 ml/min, resulting in a pressure of cm H 2 0. After removal of the renal capsule, a surface area of 9 cm 2 (3 3 cm) was ablated. The blood loss was quantified by the weight difference of a swab before and after it was placed on the bleeding surface for 60 s. The weight difference marked the amount of blood loss per minute. Afterwards, samples of the ablated renal tissue were taken and fixed in 4% formalin. After being embedded in paraffin at an interval of no longer than 2 wk after the experiments, the blocks were frozen at 19 8C, sectioned, and stained with haematoxylin-eosin. The depths of the coagulation zones induced by the lasers and TURP were determined under the microscope with the use of a calibrated calliper. Statistical data are presented as mean standard deviation. Statistical significance was evaluated with the use of the unpaired Student t test. A p value < 0.05 was considered to be statistically significant. 3. Results The ablation rates of the diode laser at different generator settings compared with the KTP laser and
3 european urology 52 (2007) Fig. 1 Ablation rate of the 980-nm diode laser at various output power levels compared with the potassium-titanylphosphate (KTP) laser and transurethral resection of the prostate (TURP). Use of high-power levels of tissue ablation has increased compared with KTP laser ( p < 0.05). Only 30 s are needed to resect the same surface area with TURP. N =5 experiments were carried out per parameter. TURP are displayed in Fig. 1. In the continuous wave (cw) mode, tissue ablation increased with increasing output power levels reaching g at 120 W after 15 min. With g of tissue removal, the KTP laser displayed a significantly lower ablation capacity than the diode laser in the same time interval ( p < 0.05). In comparison with TURP, both laser devices produced a significantly lower tissue removal. Using a drag speed of 1 cm/s with a pause of 2 s between the cuts, only 30 s were needed to resect the 3 3 cm surface area because the loop wire diameter was 0.5 cm (six cuts with 5 s per cut). The tissue removal achieved in the described fashion was g in 30 s. The bleeding rates were determined with the use of the same generator settings and are displayed in Fig. 2. Tissue ablation with the diode laser at 120 W resulted in a bleeding rate of g/min, which was not significantly different from the g/min rate of the KTP laser, whereas Fig. 2 Bleeding rate of the 980-nm diode laser at various output power levels compared with the potassium-titanylphosphate (KTP) laser and transurethral resection of the prostate (TURP) in a logarithmical scale. For both lasers, bleeding rate is reduced approximately by the factor 100 compared with TURP ( p < 0.05; n = 5).
4 1726 european urology 52 (2007) Fig. 3 Comparison of coagulation zone depth achieved with the 980-nm diode laser at different output power levels, potassium-titanyl-phosphate (KTP) laser, and transurethral resection of the prostate (TURP). The KTP laser displays a significantly higher coagulation depth than TURP and the diode laser ( p < 0.05; n = 5). TURP resulted in a significantly increased bleeding rate of g/min ( p < 0.05). Histological examination revealed that diode laser ablation resulted in a dense coagulation zone that increased with the output powers as displayed in Fig. 3. At 120 W, the coagulation zone depth was similar to that reached with TURP and significantly lower compared with the KTP laser. In addition to evaluation in the cw mode, experiments using the pulsed mode were also performed. The results are displayed in Table 1. Using the pulsed mode at a fixed pulse length of 0.1 s and varying pause lengths, we found that the ablation rate remained unchanged compared with the cw mode at 100 W. In contrast, bleeding increased in the pulsed mode with decreasing frequency. The sizes of coagulation zones were equal to those of the cw mode. 4. Discussion Although TURP is considered a reference standard in surgical therapy of BPE, it is associated with a certain morbidity, mainly caused by perioperative bleeding requiring transfusion or reintervention and irrigation fluid absorption (TUR syndrome) [9 11]. Therefore, a growing number of less invasive treatment modalities have been introduced in the last 2 decades, including several laser devices. The most widely used laser types comprise Nd:YAG, Ho:YAG, and KTP laser. The surgical techniques and treatment outcomes of these lasers are strongly dependent on the physical properties of the laser wavelengths. Because the wavelength of the Nd:YAG laser (1064 nm) displays a low absorption in prostatic tissue, it creates deep coagulation necrosis without any instant tissue removal displaying minimal blood loss. Treatment of BPE with the Nd:YAG laser is therefore characterised by long postoperative catheterisation times because the treatment success can take several weeks to set in. Furthermore, several studies have reported a low long-term durability of treatment success, leading to retreatment rates of over 20% after 2 yr [12,13]. In contrast to the Nd:YAG laser, the wavelength of the Ho:YAG laser (2140 nm) is highly absorbed in Table 1 Tissue ablation, bleeding rate, and coagulation depth of the diode laser at 100 W in the continuous wave (cw) and pulsed mode at a fixed pulse length of 0.1 s and varying pause lengths Parameter * cw mode Pulse pause 0.01 s Pulse pause 0.05 s Pulse pause 0.1 s Tissue ablation rate (g/10 min) Bleeding rate (g/min) Coagulation zone depth (mm) cw, continuous wave. * Bleeding increases with decreasing frequencies, while tissue ablation and coagulation zone depth are not altered. N = 5 experiments were carried out per parameter.
5 european urology 52 (2007) prostatic tissue, leading to instant vaporization without a considerable coagulation necrosis. Because simple ablative techniques proved to be rather time consuming, the use of the Ho:YAG laser for BPE treatment evolved to the more time-efficient techniques of holmium laser resection of the prostate (HoLRP) and holmium laser enucleation of the prostate (HoLEP). All described techniques display a low perioperative complication rate and produce durable results with low retreatment rates in the follow-up [14 17]. However, the learning curve for the more time-efficient techniques is rather steep, limiting the widespread use of these techniques. The wavelength of the widely used KTP laser (532 nm) offers above all a good haemostasis because it is strongly absorbed by haemoglobin. The laser energy is delivered via a side-fire fibre and produces instant vaporization of prostatic tissue. The technique is easy to learn, is associated with low perioperative morbidity, and produces results similar to those of TURP [6,18]. However, only limited long-term data are available, and treatment times are rather long because tissue vaporization is time consuming [4 6], limiting the patient collective to those with smaller glands. A diode laser working on a wavelength of 980 nm has been introduced lately to overcome the described problems of the established laser devices. Because this wavelength offers the highest simultaneous absorption in water and haemoglobin, it is postulated to combine high tissue ablation capacity and good haemostasis. Further advantages of the diode laser over KTP and Ho:YAG laser devices include a significantly lower energy consumption and the absence of a required high-voltage connexion, which improves mobility of the laser generator. In our ex vivo model we found tissue ablation to be easily feasible with the diode laser. The amount of removed tissue increased with longer treatment times and higher generator output power levels. We found the ablation capacity of the diode laser significantly higher compared with the KTP laser. Using the maximal output power of 120 W almost doubled the tissue removal reached with the KTP laser. Compared with TURP, the diode laser had significantly lower ablation capacity, which is, at least in part, due to limitations of our model (the cuts could be performed with a constant drag speed without the need to pause for coagulation). In vivo, the situation is different: Because a substantial amount of time is needed to coagulate bleeding vessels to minimize blood loss and increase intraoperative visibility in TURP, this procedure s advantage in time saving may be less pronounced. However, in clinical trials comparing Ho:YAG or KTP laser vaporization of the prostate with TURP, prolonged operation times were reported for the laser devices [6,15]. Our ex vivo results suggest that the 980-nm diode laser might overcome this problem because tissue ablation was almost twice as high as that reached with the KTP laser. The most appreciated advantage of KTP laser treatment is the almost bloodlessness of the procedure. Reich and colleagues [4] compared the KTP laser with TURP in a similar ex vivo model and found a significantly lower bleeding rate for the laser device. Our findings affirm their results and displayed a bleeding rate reduced by the factor 100 compared with TURP. Tissue ablation with the 980-nm diode laser resulted in bleeding similar to that of the KTP laser in the ex vivo model, indicating equal haemostatic properties. Clinical application of the diode laser has to show if these effects will be confirmed when used in vivo. Evaluation of the histological samples of ablated tissue revealed uniform and dense coagulation zones for the laser devices. Compared with the diode laser, TURP resulted in a coagulation zone of equal depth, but the coagulated tissue layer appeared less dense. The zone of coagulated tissue induced by the KTP laser was approximately twice as thick and appeared as equally dense as that of the diode laser. Our results for the diode laser suggest that a large amount of the energy is absorbed at the surface, resulting in vaporization of the tissue. In contrast, with the KTP laser, less energy is absorbed at the surface, resulting in deeper penetration and less vaporization of the tissue. This hypothesis explains the higher ablation capacity and lower coagulation zone depth of the diode laser. In addition to the described experiments using the diode laser in the cw mode, we performed further trials evaluating the performance when a pulsed mode was selected. Decreasing the frequency in the pulsed mode resulted in no change in the tissue ablation capacity, whereas bleeding increased with lower frequencies. According to these findings, we suggest using the laser in the cw mode in clinical application. Several studies prove laser vaporization of the prostate a safe and efficient method for BPE treatment [5,6,14,15,18]. However, a disadvantage of the technique is the rather low tissue ablation capacity of the established Ho:YAG and KTP laser devices, resulting in prolonged operation times. Our ex vivo findings suggest that the diode laser might have the potential to overcome this problem. In the ex vivo model, the diode laser showed a higher
6 1728 european urology 52 (2007) tissue ablation capacity and equal haemostatic properties compared with the KTP laser. Although the model we used provides a wellestablished tool for systematic evaluation of ablative devices, we are aware of the limitations of the study. All experiments were performed by using a blood-perfused porcine kidney in an ex vivo setting, which does not resemble human prostatic tissue in vivo in every aspect. Therefore, the results concerning ablative and haemostatic properties of the devices may be different when used in vivo. However, because the specific heat capacities in the renal and prostatic tissue are very similar, the blood-perfused kidney is a valuable model for studying laser procedures, in which the heat sink is of major importance [19]. Therefore, we believe our promising results warrant further clinical evaluation of the laser device to determine if its advantages found in the ex vivo setting offer a benefit in the in vivo setting. 5. Conclusions The 980-nm diode laser displays an increased tissue ablation capacity and equal haemostatic properties compared with the KTP laser in the ex vivo setting. In comparison with TURP, both tissue ablation and bleeding rates are significantly reduced. Our promising results warrant further clinical evaluation of the laser. Conflicts of interest The authors have nothing to disclose. Acknowledgements The authors thank Endrik Groenhoff from Biolitec AG for his technical support. References [1] Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83: [2] Fried NM. New laser treatment approaches for benign prostatic hyperplasia. Curr Urol Rep 2007;8: [3] Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49: [4] Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171: [5] Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64: [6] Bachmann A, Schürch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48: [7] Michel MS, Kohrmann KU, Weber A, Krautschick AW, Alken P. Rotoresect: new technique for resection of the prostate: experimental phase. J Endourol 1996;10: [8] Wendt-Nordahl G, Häcker A, Reich O, Djavan B, Alken P, Michel MS. The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol 2004;46: [9] Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141: [10] Horninger W, Unterlechner H, Strasser H, Bartsch G. Transurethral prostatectomy: mortality and morbidity. Prostate 1996;28: [11] Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) incidence, management, and prevention. Eur Urol 2006;50: [12] Laguna MP, Alivizatos G, De La Rosette JJ. Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol 2003;17: [13] Muschter R. Free-beam and contact laser coagulation. J Endourol 2003;17: [14] Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR. Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 2003;92: [15] Mottet N, Anidjar M, Bourdon O, et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999;13: [16] Gilling PJ, Kennett KM, Fraundorfer MR. Holmium laser enucleation of the prostate for glands larger than 100 g: an endourologic alternative to open prostatectomy. J Endourol 2000;14: [17] Wilson LC, Gilling PJ, Williams A, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006;50: [18] Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20: [19] Cooper TE, Trezek GJ. A probe technique for determining the thermal conductivity of tissue. J Heat Transfer 1972;94:133.
The Vista System: A New Bipolar Resection Device for Endourological Procedures: Comparison with Conventional Resectoscope
European Urology European Urology 46 (2004) 586 590 The Vista System: A New Bipolar Resection Device for Endourological Procedures: Comparison with Conventional Resectoscope Gunnar Wendt-Nordahl a, *,AxelHäcker
More informationSubmitted: August 15, Accepted: September 10, Published: October 15, 2018.
Original Article doi: 10.22374/jeleu.v1i2.21 THULIUM LASER ENUCLEATION OF THE PROSTATE (THULEP) AS A TECHNIQUE FOR TREATMENT OF BPH: EVALUATION OF A SIX-YEAR EXPERIENCE AT A SINGLE INSTITUTION Mahmood
More informationLasers in Urology. An Evidence-Based Approach to Choosing the Right Tool
Lasers in Urology An Evidence-Based Approach to Choosing the Right Tool Today medical lasers and specifically designed optical fibers offer benefits in a variety of surgical applications. Selecting the
More informationISPUB.COM. Photoselective Vaporisation of the Prostate - Independent Surgical Experience Following Comprehensive Resident Training in the Technique.
ISPUB.COM The Internet Journal of Urology Volume 9 Number 4 Photoselective Vaporisation of the Prostate - Independent Surgical Experience Following Comprehensive Resident Training in the Technique. R Eapen,
More informationThulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial
european urology 53 (2008) 382 390 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Obstruction Thulium Laser versus Standard Transurethral Resection of the
More informationEUROPEAN UROLOGY 58 (2010)
EUROPEAN UROLOGY 58 (2010) 349 355 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Benign Prostatic Hyperplasia Editorial by Petrisor Geavlete on pp. 356
More informationTransurethral Laser Technology: Treatments for BPH
Transurethral Laser Technology: Treatments for BPH Richard Lee, MD Departments of Urology and Public Health The New York Presbyterian Hospital Weill Medical College of Cornell University Background Traditional
More informationTechnique and Short-Term Outcome of Green Light Laser (KTP, 80 W) Vaporisation of the Prostate
european urology 52 (2007) 1632 1637 available at www.sciencedirect.com journal homepage: www.europeanurology.com Surgery in Motion Technique and Short-Term Outcome of Green Light Laser (KTP, 80 W) Vaporisation
More informationSe-Hee Kang, Yong Sun Choi, Su Jin Kim, Hyuk Jin Cho, Sung-Hoo Hong, Ji Youl Lee, Tae-Kon Hwang, Sae Woong Kim
www.kjurology.org DOI:10.4111/kju.2011.52.4.260 Lasers in Urology Long-Term Follow-Up Results of Photoselective Vaporization of the Prostate with the 120 W Greenlight HPS Laser for Treatment of Benign
More informationThe One Year Outcome after KTP Laser Vaporization of the Prostate According to the Calculated Vaporized Volume
J Korean Med Sci 9; 24: 1187-91 ISSN 111-8934 DOI: 1.3346/jkms.9.24.6.1187 Copyright The Korean Academy of Medical Sciences The One Year Outcome after KTP Laser Vaporization of the Prostate According to
More informationDiode Laser Treatment of Human Prostates
Original Article Diode Laser Treatment of Human Prostates Mohammad Reza Razzaghi, Hooman Mokhtarpour, Mohammad Mohsen Mazloomfard Laser Application in Medical Sciences Research Center, Shahid Beheshti
More informationLasers in Urology. Laser Tissue Interaction, November 28 th, Qureshi, Muhammad Mohsin. Biomedical in vivo Opto-scopy Laboratory
Laser Tissue Interaction, November 28 th, 2016 Lasers in Urology Qureshi, Muhammad Mohsin Gwangju Institute of Science and Technology Biomedical in vivo Opto-scopy Laboratory 2 Content Introduction to
More informationInitial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj
Original Article Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj Abstract Objectives: Prospective evaluation
More informationHOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION.
IN YOUR HANDS HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT LASER AT YOUR SIDE IN YOUR HANDS is a high power holmium laser
More informationOriginal Article - Lasers in Urology. Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, Youn Soo Jeon
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.11.737 Original Article - Lasers in Urology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.11.737&domain=pdf&date_stamp=2014-11-16
More informationHOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT
IN YOUR HANDS HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT Manufactured by Asclepion Laser Technologies GmbH LASER AT
More informationComplications of Diode Laser in Endourological Procedures in Co-morbid Patients
ORIGINAL ARTICLE Complications of Diode Laser in Endourological Procedures in Co-morbid Patients Farooq Hameed, Mohammad Imran Zahoor, Javed Aziz, Saadat Hashmi, Abdul Jalil, Abdul Rehman ABSTRACT Objective:
More informationSAFE EFFECTIVE EASY & VERSATILE PATIENT FRIENDLY. Laser wavelength highly absorbed by H 2
biolitec in Urology SAFE Laser wavelength highly absorbed by H 2 O Allowing contact use for tactile feedback and control Less risk of complications EFFECTIVE High success rate even in outpatient setting
More informationBenign enlargement of prostate (BEP), which is. Early Experiences with HoLEP. Original Article ABSTRACT INTRODUCTION. Bhandari BB*
Original Article Early Experiences with HoLEP Bhandari BB* * Consultant Urologist, Shree Birendra Army Hospital, Norvic International Hospital, Alka Hospital ABSTRACT introduction: Holmium Laser Enucleation
More informationOutcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study
Original Article - Lower Urinary Tract Dysfunction pissn 2466-0493 eissn 2466-054X Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study M. Hammad Mithani, Salman
More informationeuropean urology 54 (2008)
european urology 54 (2008) 427 437 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Obstruction Transurethral Photoselective Vaporization versus Transvesical
More informationComparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study
original research Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study Jae Heon Kim, MD; * Jae Young Park,
More informationLasers in Urology. Ju Hyun Park 1, Hwancheol Son 1,2, Jae-Seung Paick 1. DOI: /kju
www.kjurology.org DOI:10.4111/kju.2010.51.2.115 Lasers in Urology Comparative Analysis of the Efficacy and Safety of Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia
More informationVaporization of the Prostate with 150-W Thulium Laser: Complications with 6-Month Follow-Up
JOURNAL OF ENDOUROLOGY Volume XX, Number XX, XXXX 2014 ª Mary Ann Liebert, Inc. Pp. --- --- DOI: 10.1089/end.2013.0715 Technology Vaporization of the Prostate with 150-W Thulium Laser: Complications with
More informationA Review of the Recent Evidence ( ) for 532-nm Photoselective Laser Vaporisation and Holmium Laser Enucleation of the Prostate
european urology 55 (2009) 1345 1357 available at www.sciencedirect.com journal homepage: www.europeanurology.com Review Benign Prostatic Obstruction A Review of the Recent Evidence (2006 2008) for 532-nm
More informationCan 80 W KTP Laser Vaporization Effectively Relieve the Obstruction in Benign Prostatic Hyperplasia?: A Nonrandomized Trial
pissn: 2287-428 / eissn: 2287-469 World J Mens Health 212 December 3(3): 16-165 http://dx.doi.org/1.5534/wjmh.212.3.3.16 Original Article Can 8 W KTP Laser Vaporization Effectively Relieve the Obstruction
More informationHolmium:YAG Transurethral Incision Versus Laser Photoselective Vaporization for Benign Prostatic Hyperplasia in a Small Prostate
Holmium:YAG Transurethral Incision Versus Laser Photoselective Vaporization for Benign Prostatic Hyperplasia in a Small Prostate Ahmed M. Elshal, Mohamed A. Elkoushy, Hazem M. Elmansy, John Sampalis and
More informationPREDICTORS OF ENUCLEATION AND MORCELLATION TIME DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE
PREDICTORS OF ENUCLEATION AND MORCELLATION TIME DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE M Francesca Monn, Marawan El Tayeb, Naeem Bhojani, Matthew J. Mellon, James C. Sloan, Ronald S. Boris, James
More informationPHOTOSELECTIVE POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION OF THE BENIGN OBSTRUCTIVE PROSTATE: OBSERVATIONS ON LONG-TERM OUTCOMES
0022-5347/05/1744-1344/0 Vol. 174, 1344 1348, October 2005 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2005 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000173913.41401.67 PHOTOSELECTIVE
More informationSurgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan
International Journal of Urology (2011) 18, 166 170 doi: 10.1111/j.1442-2042.2010.02687.x Short Communicationiju_2687 166..170 Surgical procedures for benign prostatic hyperplasia: A nationwide survey
More informationExecutive Summary. Non-drug local procedures for treatment of benign prostatic hyperplasia 1. IQWiG Reports - Commission No.
IQWiG Reports - Commission No. N04-01 Non-drug local procedures for treatment of benign prostatic hyperplasia 1 Executive Summary 1 Translation of the executive summary of the final report Nichtmedikamentöse
More informationEarly-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP)
JRural Med 2007 ; 2 : 93 97 Original article Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP) Shuzo Hamamoto 1,TakehikoOkamura 1,HideyukiKamisawa 1,KentaroMizuno 1,
More informationCheng Liu, Xuejun Liu, Duo Liu, Jiagui Mu, Dongsheng Zhu, Li Fan, Qun Song, Dongwei Yao *
Biomedical Research 2017; 28 (5): 2278-2283 ISSN 0970-938X www.biomedres.info Effect of dual-band semiconductor laser transurethral resection of prostate on efficacy, stress response and quality of life
More informationBENIGN PROSTATIC HYPERPLASIA (BPH) affects 70%
JOURNAL OF ENDOUROLOGY Volume 14, Number 2, March 2000 Mary Ann Liebert, Inc. Holmium Laser Enucleation of the Prostate With Tissue Morcellation: Initial United States Experience JEFFREY A. MOODY, M.D.,
More informationSafety and efficacy of photoselective vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants
Clinical Report Safety and efficacy of photoselective vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants Journal of International Medical Research
More informationThe impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review
500 Review Asian Journal of Andrology (2010) 12: 500 508 2010 AJA, SIMM & SJTU All rights reserved 1008-682X/10 $ 32.00 www.nature.com/aja The impact of minimally invasive surgeries for the treatment of
More informationCombination of Thulium Laser Incision and Bipolar Resection Offers Higher Resection. Velocity than Bipolar Resection Alone in Large Prostates
Running Head: combination of thulium laser and bipolar in endoscopic prostatectomy-huang et al. Combination of Thulium Laser Incision and Bipolar Resection Offers Higher Resection Velocity than Bipolar
More informationAgenda of Product Presenta0on. I. Introduc*on II. Laser Physics III. Key Advantages IV. Clinical Data V. Key Takeaways
Agenda of Product Presenta0on I. Introduc*on II. Laser Physics III. Key Advantages IV. Clinical Data V. Key Takeaways 1 Applica0ons of DIOLAS LFD 3000 at a Glance Benign Prostatic Hyperplasia (BPH) Destruction
More informationBenign prostatic hyperplasia (BPH) is one of the
MISCELLANEOUS Safety and Efficacy of Bipolar Versus Monopolar Transurethral Resection of the Prostate: A Comparative Study Erkan Hirik, 1 Aliseydi Bozkurt, 1 Mehmet Karabakan, 1 * Huseyin Aydemir, 2 Binhan
More informationThe evaluation of tissue mass loss in the incision line of prostate with benign hyperplasia performed using holmium laser and cutting electrode
282 Original Paper FUNCTIONAL UROLOGY The evaluation of tissue mass loss in the incision line of prostate with benign hyperplasia performed using holmium laser and cutting electrode Mariusz Szewczyk 1,
More informationOriginal Policy Date
MP 7.01.39 Transurethral Microwave Thermotherapy Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical
More informationPhotoselective vaporization of the prostate towards a new standard
(2007) 10, S10 S14 & 2007 Nature Publishing Group All rights reserved 1365-7852/07 $30.00 ORIGINAL ARTICLE www.nature.com/pcan towards a new standard Galway Clinic, Doughiska, Galway, Ireland Many technologies
More informationEarly outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate
Singapore Med J 2016; 57(12): 676-680 doi: 10.11622/smedj.2016026 Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate Sundaram Palaniappan
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationIS IRRIGATION NECESSARY AFTER MONOPOLAR TURP? OUR 11 YEARS EXPERIENCE
IS IRRIGATION NECESSARY AFTER MONOPOLAR TURP? OUR 11 YEARS EXPERIENCE Prasannakumar K, Venkatesh Krishnamoorthy, Maneesh Sinha, Krishna Prasad T, Pradeepa MG Abstract Objective: This study was conducted
More informationInitial Experience with Vaporization of Benign or Cancerous Prostate using 980-nm Diode Laser
Article ID: WMC002526 ISSN 2046-1690 Initial Experience with Vaporization of Benign or Cancerous Prostate using 980-nm Diode Laser Corresponding Author: Dr. Tine Hajdinjak, Urologist, Division of Urology,
More informationHolmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results
www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.11.779 Voiding Dysfunction Holmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results Su Hyung Lee, Jong In Choi, Kyung
More informationTreating BPH: Comparing Rezum UroLift and HoLEP
Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline
More informationLasers in Urology. Sae Woong Choi, Yong Sun Choi, Woong Jin Bae, Su Jin Kim, Hyuk Jin Cho, Sung Hoo Hong, Ji Youl Lee, Tae Kon Hwang, Sae Woong Kim
www.kjurology.org http://dx.doi.org/10.4111/kju.2011.52.12.824 Lasers in Urology 120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in
More informationRandomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia
ORIGINAL RESEARCH Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia Thomas A.A. Skinner, MSc, MD; Robert J. Leslie, MSc, MD; Stephen S. Steele,
More informationReview Article A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment
Advances in Andrology, Article ID 207901, 6 pages http://dx.doi.org/10.1155/2014/207901 Review Article A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment Bilal Chughtai, Claire Dunphy,
More informationTRANSURETHRAL PLASMA VAPORIZATION OF THE PROSTATE Procedure Guide
TRANSURETHRAL PLASMA VAPORIZATION OF THE PROSTATE Procedure Guide 16299 1 PLASMA VAPORIZATION THERAPY PLASMA Vaporization PLASMA vaporization provides a safe, easy-to-use solution for TUR tissue-management
More informationREVIEWS. Laser treatment of benign prostate enlargement which laser for which prostate? Malte Rieken and Alexander Bachmann
Laser treatment of benign prostate enlargement which laser for which prostate? Malte Rieken and Alexander Bachmann Abstract Laser-based prostatectomy for benign prostatic obstruction has emerged over the
More informationOriginal Article HoLEP: the gold standard for the surgical management of BPH in the 21 st Century
Am J Clin Exp Urol 2015;3(1):36-42 www.ajceu.us /ISSN:2330-1910/AJCEU0007305 Original Article HoLEP: the gold standard for the surgical management of BPH in the 21 st Century John Michalak, David Tzou,
More informationEfficacy and safety of photoselective vaporization of the prostate in patients with prostatic obstruction induced by advanced prostate cancer
Asian Journal of Surgery (2011) 34, 135e139 Available online at www.sciencedirect.com journal homepage: www.e-asjsur.com ORIGINAL ARTICLE Efficacy and safety of photoselective vaporization of the prostate
More informationBimalesh Purkait, Rahul Janak Sinha, Krishna Swamy A. Srinivas, Ankur Bansal, Ashok Kumar Sokhal, Vishwajeet Singh
176 Turk J Urol 2017; 43(2): 176-82 DOI: 10.5152/tud.2017.20586 GENERAL UROLOGY Original Article Outcome analysis of transurethral resection versus potassium titanyl phosphate-photo selective vaporization
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with
More informationName of Policy: Transurethral Microwave Thermotherapy
Name of Policy: Transurethral Microwave Thermotherapy Policy #: 449 Latest Review Date: September 2013 Category: Surgery Policy Grade: B Background/Definitions: As a general rule, benefits are payable
More informationVaporization of Prostatic Tissue to Treat Benign Prostatic Hyperplasia
Vaporization of Prostatic Tissue to Treat Benign Prostatic Hyperplasia BEE 4530: Computer Aided Engineering Group 3: Dan Currie Elaina Griffo Jin Kim Sarah Wheeling Table of Contents 1. Executive Summary...2
More informationReview of Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.6.351 Review Article Review of Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia E. Charles Osterberg, Benjamin B. Choi Department
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationAMERIHEALTH / INDEPENDENCE BLUE CROSS
AMERIHEALTH / INDEPENDENCE BLUE CROSS Urinary outlet obstruction is difficulty in the passage of urine from the bladder to the urethra caused by compression or resistance on the bladder outflow channel
More informationLasers in Urology. Hyeon Jun Kim, Han Yi Lee, Sang Hun Song 1, Jae-Seung Paick.
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.2.89 Lasers in Urology Relationship of Postoperative Recatheterization and Intraoperative Bladder Distention Volume in Holmium Laser Enucleation
More informationTechniques and Training with GreenLight HPS 120-W Laser Therapy of the Prostate: Position Paper
european urology supplements 7 (2008) 370 377 available at www.sciencedirect.com journal homepage: www.europeanurology.com Techniques and Training with GreenLight HPS 120-W Laser Therapy of the Prostate:
More informationLong-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia
Journal of Surgery 2016; 4(2): 40-44 http://www.sciencepublishinggroup.com/j/js doi: 10.11648/j.js.20160402.18 ISSN: 2330-0914 (Print); ISSN: 2330-0930 (Online) Long-term Follow-up of Transurethral Enucleation
More informationGUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,
More informationEfficacy and Safety of Laser Surgery and Transurethral Resection of the Prostate for Treating Benign Prostate Hyperplasia: a Network Meta-analysis
APJCP.2016.17.9.4281 Efficacy and Safety of Laser Surgery and Transurethral Resection of the Prostate for Treating BPH: a Network Meta-analysis RESEARCH ARTICLE Efficacy and Safety of Laser Surgery and
More informationKhae Hawn Kim, Kwang Taek Kim, Jin Kyu Oh, Kyung Jin Chung, Sang Jin Yoon, Han Jung, Tae Beom Kim
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2018 January 36(1): 79-86 https://doi.org/10.5534/wjmh.17039 Original Article Enucleated Weight/Enucleation Time, Is It Appropriate for Estimating
More informationBJUI. GreenLight laser prostatectomy: a safe and effective treatment for bladder outlet obstruction by prostate cancer
. JOURNAL COMPILATION 2010 Lower Urinary Tract GREENLIGHT LASER PROSTATECTOMY LIBERALE ET AL. BJUI GreenLight laser prostatectomy: a safe and effective treatment for bladder outlet obstruction by prostate
More informationHolmium Laser Enucleation versus Transurethral Resection of the Prostate: 3-Year Follow-Up Results of a Randomized Clinical Trial
european urology 52 (2007) 1456 1464 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia Holmium Laser Enucleation versus Transurethral Resection of
More informationComplications and Early Postoperative Outcome in 1080 Patients After Thulium Vapoenucleation of the Prostate: Results at a Single Institution
EUROPEAN UROLOGY 63 (2013) 859 867 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Benign Prostatic Obstruction Editorial by Peter J. Gilling on pp. 868 869
More informationINJINTERNATIONAL. Original Article INTRODUCTION. Int Neurourol J 2017;21: pissn eissn
Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and
More informationRezūm procedure for the Prostate
Rezūm procedure for the Prostate Mr Jas Kalsi Consultant Urological Surgeon This booklet has been provided to help answer the questions you may have with regards to your enlarged prostate and the Rezūm
More informationWednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario
Wednesday 25 June 14.30 15.30 Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario P080 Unreliable residual volume measurement after increased water load diuresis G. ALIVIZATOS, A. SKOLARIKOS,
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE The UroLift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 1
More informationVoiding Dysfunction. Joon Seok Kwon, Jung Woo Lee 1, Seung Wook Lee, Hong Yong Choi, Hong Sang Moon. DOI: /kju
www.kjurology.org DOI:10.4111/kju.2011.52.4.269 Voiding Dysfunction Comparison of Effectiveness of Monopolar and Bipolar Transurethral Resection of the Prostate and Open Prostatectomy in Large Benign Prostatic
More informationHolmium laser enucleation of the prostate can be taught: the first learning experience
Blackwell Science, LtdOxford, UK BJUBJU International1464-4096BJU International 909December 2002 3071 LEARNING HoLEP A. EL-HAKIM and M.M. ELHILALI 10.1046/j.1464-4096.2002.03071.x Original Article863869BEES
More informationYong Taec Lee, Young Woo Ryu, Dong Min Lee, Sang Wook Park, Seung Hee Yum, June Hyun Han
www.kjurology.org http://dx.doi.org/10.4111/kju.2011.52.11.763 Voiding Dysfunction Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral
More informationChanges in Surgical Strategy for Patients with Benign Prostatic Hyperplasia: 12-Year Single-Center Experience
www.kjurology.org DOI:10.4111/kju.2011.52.3.189 Voiding Dysfunction Changes in Surgical Strategy for Patients with Benign Prostatic Hyperplasia: 12-Year Single-Center Experience Yu Seob Shin 1, Jong Kwan
More informationEFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT
EFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT Hasmeinda Medical faculty of Universitas Muhammadiyah Surakarta ABSTRACT Benign prostatic hyperplasia (BPH) is the most important cases
More informationProstatic Diseases and Male Voiding Dysfunction
Prostatic Diseases and Male Voiding Dysfunction Prostatic-specific Antigen Velocity After Holmium Laser Enucleation of the Prostate: Possible Predictor for the Assessment of Treatment Effect Durability
More informationSurgical Treatment of LUTS in Men with BPE
Patient Information English 35 Surgical Treatment of LUTS in Men with BPE The underlined terms are listed in the glossary. You have been diagnosed with benign prostatic enlargement (BPE) and your doctor
More informationHolmium laser enucleation of the prostate: a review of the clinical trial evidence
511509TAU0010.1177/1756287213511509Therapeutic Advances in UrologyM Cynk 2013511509 Therapeutic Advances in Urology Review Holmium laser enucleation of the prostate: a review of the clinical trial evidence
More informationABSTRACT KEY WORDS. Original Article. Page 163. Background
Outcomes of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Comparing Prostate Size of more than 80 Grams to Prostate Size less than 80 Grams. Joshi HN, 1 de Jong IJ, 2 Karmacharya
More informationBipolar Transurethral Resection of the Prostate: Perioperative Safety and Functional Outcome: Prospective Randomized Study
World Journal of Medical Sciences 11 (4): 439-444, 014 ISSN 1817-3055 IDOSI Publications, 014 DOI: 10.589/idosi.wjms.014.11.4.866 Bipolar Transurethral Resection of the Prostate: Perioperative Safety and
More informationExperience the Innovative Therapy for Benign Prostate Enlargement
Experience the Innovative Therapy for Benign Prostate Enlargement A Guide to Treatment of Benign Prostatic Hyperplasia 1. 2. The Prostate The prostate gland is a part of the male reproductive system. A
More informationBenign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome
More informationIncreasing life expectancy has resulted in an increase in
Laser prostatectomy versus transurethral resection of prostate in the treatment of benign prostatic hyperplasia Mohammad-Reza Razzaghi, MD, Gholamreza Habibi, MD, Gholamreza E. Djavid, MD, Hamidreza Gholamrezaee,
More informationService Line: Rapid Response Service Version: 1.0 Publication Date: March 01, 2017 Report Length: 16 Pages
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Bipolar versus Monopolar Transurethral Resection of the Prostate or GreenLight Laser Treatment: A Review of Clinical and Cost-Effectiveness
More informationRFA is an attractive, heat energy based ablation modality
Bipolar and Multipolar Radio Frequency Ablation With Resistance Controlled Power Output: Standardized Ex Vivo Kidney Tissue Evaluation Axel Häcker,* Stefan Vallo, Christel Weiss, Rainer Grobholz, Thomas
More informationA rapid scan of the literature
A rapid scan of the literature August 2009 Photoselective vaporisation for benign prostatic hyperplasia: a rapid literature scan Gregory Merlo Suzanne Campbell Adele Weston This report should be referenced
More informationNOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate
NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December
More informationInterstitial Laser Coagulation Treatment of Benign Prostatic Hyperplasia: Is It to Be Recommended?
JOURNAL OF ENDOUROLOGY Volume 17, Number 8, October 2003 Mary Ann Liebert, Inc. Interstitial Laser Coagulation Treatment of Benign Prostatic Hyperplasia: Is It to Be Recommended? M. PILAR LAGUNA, M.D.,
More informationEnergy Delivery Systems for Treatment of Benign Prostatic Hyperplasia
Ontario Health Technology Assessment Series 2006; Vol. 6, No. 17 Energy Delivery Systems for Treatment of Benign Prostatic Hyperplasia An Evidence-Based Analysis August 2006 Medical Advisory Secretariat
More informationTransurethral Resection of Ejaculatory Duct Obstruction: Monopolar, Bipolar or Holmium Laser?
Transurethral Resection of Ejaculatory Duct Obstruction: Monopolar, Bipolar or Holmium Laser? Selahittin Çayan, MD, FECSM Professor of Urology University of Mersin School of Medicine, Department of Urology,
More informationEAU GUIDELINES POCKET EDITION 3
EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books
More informationInitial evaluation of the use of the potassium-titanyl-phosphate (KTP/532)* laser in gynecologic laparoscopy
-- FERTU.JTY AND STERILITY Copyright c 1986 The American Fertility Society Printed in U.SA. Initial evaluation of the use of the potassium-titanyl-phosphate (KTP/532)* laser in gynecologic laparoscopy
More informationCitation Acta medica Nagasakiensia. 1997, 42
NAOSITE: Nagasaki University's Ac Title Author(s) The Relation of Prostate Tissue Pro Transmissibility and Thermal Effect Kubota, Sigehiro; Yushita, Yoshiaki Yoshikazu; Daikuzono, Norio Citation Acta medica
More information